![]() |
|||||||||||
| Media | |||||||||||
News Articles:
Cequent Pharmaceuticals, Inc.: the biological pitcher for RNAi therapeutics. (Pharmacogenomics July 2007, Vol. 8, No. 7, Pages 867-871)
Cequent gets a hand from Swiss giant's venture arm. (Boston Business Journal - subscription required)
Bugs bear RNA drugs. A Cambridge startup is using bacteria to deliver the promise of RNAi therapeutics. (Nature Network - Boston)
Quark, Cequent Present Rodent Data in Beyond Genome Poster Presentations (RNAi News - subscription required)
Cequent Nabs Additional $3M in Series A; Novartis Takes Option to IBD Program (RNAi News - subscription required)
Cequent Nabs $9 Million Funds will harness bacteria found in yogurt to fight cervical cancer. (Red Herring)
Biotech's next big thing catching on. RNAi technology fights bad genes and attracts big money. (Boston Business Journal - subscription required)
Startup Cequent Jumps Onto RNAi Drugs Field With $6M VC Funding and Novel Delivery Tech. (RNAi News - subscription required)
Cequent lands $6M on the Strength of Its Core Technology
How Gene Silencing May Provide Cures
Congratulations to Andrew Z. Fire and Craig C. Mello for the Nobel Prize in Physiology or Medicine, 2006. They are being honored for their discovery of "RNA interference – gene silencing by double-stranded RNA."
Videos on RNA interference by the Nature Publishing Group: For more information on either of these videos and an introduction to RNA interference, please go to http://www.nature.com/focus/rnai/index.html
1. Mechanisms of RNA interference Click on the link above to watch a movie about RNA interference (RNAi) produced by Nature Publishing Group
Quicktime is required to view the animated tour of RNAi. This animation was designed by Arkitek Studios for Nature Reviews Genetics. To download QuickTime, please click here.
Please direct media inquiries to:
Caroline A. Grossman 781.771.5579 Mobile 781.893.6758 Office/Fax Email: caroline.grossman@gmail.com
|
|||||||||||